Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001662252-19-000014
Filing Date
2019-01-31
Accepted
2019-01-31 16:30:40
Documents
1
Period of Report
2018-03-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3322
  Complete submission text file 0001662252-19-000014.txt   4827
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Issuer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address
Genkin Dmitry (Reporting) CIK: 0001711592 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37937 | Film No.: 19556235